In a study in rats with diabetes, triptolide treatment was shown to induce protection against myocardial fibrosis and the associated impaired left ventricular function by suppressing both the TLR-4 and NF-kB pathways. This evidence concerns the gene NFKB1 and Myocardial fibrosis.